La reconocida vacunóloga Bottazzi, nominada al Nobel de la Paz, asiste al VI Congreso del Idis
Santiago. La profesora María Elena Bottazzi, vacunóloga de prestigio internacional y nominada recientemente al Nobel de la Paz por ser co-creadora de …
Related Articles
Breaking Barriers: Wisdom and Insights of Women Leaders in Vaccinology
Mother’s Day is a perfect time to celebrate the wisdom and insights of women leaders in the field of vaccinology. Read on for a preview…
A Data-Driven Approach to Construct a Molecular Map of Trypanosoma cruzi to Identify Drugs and Vaccine Targets
Chagas disease (CD) is endemic in large parts of Central and South America, as well as in Texas and the southern regions of the United…
2022 DALLAS MORNING NEWSMaría Elena Bottazzi and Peter Hotez – Dallas Morning News
Houston microbiologists gave the world a patent-free COVID-19 vaccine and are on the trail of eradicating neglected tropical diseasesScientific discoveries are thrilling because they’re stories…
Personaje del año: María Elena Bottazzi, líder mundial en vacunas – Diario La Tribuna
LA TRIBUNA declara como personaje del año a la doctora María Elena Bottazzi por su destacada carrera médica, sus aportes a la luch…
Les femmes les plus créatives du monde – Le Filtre
Parce que la rentrée, c’est LE moment où on a envie de réinventer – même juste un peu – sa vie professionnelle, voici 10 femmes…
Please wait whilst we redirect you
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing…
Chi è Maria Elena Bottazzi, la scienziata inventrice del vaccino senza brevetto per i Paesi poveri
Candidata al Premio Nobel per la Pace, Maria Elena Bottazzi coordina il team che ha sviluppato Corbevax, vaccino senza brevetti che costerà meno di un…
16th Vaccine Congress | 12-14 September 2022 – Elsevier
The Congress is organized by Vaccine, the premier journal for those interested in vaccine science.
19 lakh doses of Corbevax administered | Jaipur News – Times of India
People aged above 18 years are taking Corbevax as a precaution Covid-19 dose with great enthusiasm. In the state, around 32% of the doses administered
Whatever happened to the new no-patent COVID vaccine touted as a global game changer?
The inventors of Corbevax said it was cheap, easy to make, effective and safe. They hoped it could bring vaccine equity to countries that can’t…